Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

KRN-7000 for the treatment of liver metastasis

Oct. 23, 1997

Imutec's Virulizin approved in Mexico for malignant melanoma

Oct. 23, 1997

Update on development of NeoPharm's novel chimeric human protein

Oct. 21, 1997

Bexxar compared to unlabeled MAb in patients with non-Hodgkin's lymphoma

Oct. 21, 1997

Avax evaluates its ovarian cancer vaccine in phase II

Oct. 20, 1997

New GVAX cancer vaccine begins human testing

Oct. 17, 1997

Jenner Technologies initiates clinical testing of AdjuVax-100a

Oct. 16, 1997

Meeting of Biological Response Modifiers Advisory Committee this week

Oct. 14, 1997

Cancer cells being used to treat cancer

Oct. 13, 1997

Phase II results for IDEC-C2B8 in NHL

Oct. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...